US Stocks Movement | Q3 Turns Profitable with Significant Upward Revision of Full-Year Revenue Guidance, Moderna (MRNA.US) Rises Over 5%

Zhihu Finance APP reports that on Friday, Moderna (MRNA.US) rose by over 5%, closing at $254.36. According to reports, Moderna announced its third-quarter 2026 results. The financial report shows that the company’s total revenue was $1.313 billion, an increase of 29% year-on-year, significantly higher than the market expectation of about $885 million; net profit reached $162 million, turning around from a net loss of $200 million in the same period last year; diluted earnings per share were $0.38, much better than the market’s expected loss of $1.25 per share.